RecruitingNCT07444697

"Erectile Function After PCI in MI and Non-MI Patients"

Erectile Function After Percutaneous Coronary Intervention in Myocardial Infarction and Non-Infarction Patients: A Prospective Comparative Study.


Sponsor

Kırıkkale University

Enrollment

100 participants

Start Date

Jan 15, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to assess changes in patients' erectile function after percutaneous coronary intervention (PCI) using a standard IIEF (International Index of Erectile Function) questionnaire at 1, 3, and 6 months post-PCI. By doing this, we try to compare patients' responses to PCI after having a heart attack and stable angina to see the real effect of myocardial infarction on erectile function status in the long term by comparing it with a very similar group.


Eligibility

Sex: MALEMin Age: 30 YearsMax Age: 75 Years

Inclusion Criteria11

  • Male patients aged 30-75 years
  • Undergoing successful percutaneous coronary intervention (PCI) for one of the following:
  • Acute myocardial infarction (Group 1)
  • Stable angina (Group 2)
  • Hemodynamically stable after the PCI procedure
  • Survival of the index hospitalization
  • Ability to provide written informed consent
  • Sexually active within the 3 months prior to enrollment
  • Willingness and ability to complete follow-up visits and questionnaires at:
  • Baseline (post-PCI recovery)
  • months

Exclusion Criteria21

  • Known malignancy (active or recently treated)
  • Neurological disorders affecting erectile function, including:
  • Spinal cord injury
  • Multiple sclerosis
  • Parkinson's disease
  • Uncontrolled diabetes mellitus (HbA1c \> 9%)
  • Presence of more than two chronic systemic diseases, such as:
  • Severe renal disease
  • Severe hepatic disease
  • Severe pulmonary disease
  • Polypharmacy, defined as chronic use of more than three daily medications
  • Absence of sexual activity or lack of a sexual partner
  • Refusal or inability to provide informed consent or complete study questionnaires
  • Severe psychiatric illness interfering with study participation
  • Endocrine disorders, including:
  • Untreated hypogonadism
  • Thyroid disease
  • Major post-PCI complications preventing participation, including:
  • Reinfarction
  • Stroke
  • Heart failure

Locations(1)

The Hospital of Kirikkale Univerity Faculty of Medicine

Kırıkkale, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07444697


Related Trials